Literature DB >> 27224497

Construct Validity of Four Frailty Measures in an Older Australian Population: A Rasch Analysis.

I S Widagdo1, N Pratt, M Russell, E E Roughead.   

Abstract

Individuals identified as frail have been shown to be at an increased risk of adverse health outcomes. However, there is no gold standard frailty measure and frailty status can vary depending on the measure used, suggesting the measures perform differently. Construct validity can be used to assess a measure's performance. This study aimed to examine the construct validity of four frailty measures in an Australian older population using Rasch analysis. Frailty status among the 2087 participants aged 65 years and above from the Australian Longitudinal Study of Ageing (ALSA) was assessed using: frailty phenotype--FP, simplified frailty phenotype--SFP, frailty index--FI, and prognostic frailty score--PFS. Rasch analysis was used to assess the unidimensionality of the measures, which is the extent to which the underlying characteristic of frailty is assessed. The criteria for unidimensionality from principal component analysis of the residuals was when 50% or more of the raw variance was explained by the measures, and less than 5% was unexplained variance. Only FI meet the unidimensionality criteria with 74% of explained variance and 2.1% of unexplained variance. SFP did not show a unidimensional construct with 13.3% of explained variance and 47.1% of unexplained variance. FP and PFS had 39.6%, 18.1% and 46.5%, 8.7% of explained and unexplained variance, respectively. Our findings showed that FI has better construct validity than the other three measures in assessing frailty among the Australian older population.

Entities:  

Mesh:

Year:  2016        PMID: 27224497     DOI: 10.14283/jfa.2016.83

Source DB:  PubMed          Journal:  J Frailty Aging        ISSN: 2260-1341


  9 in total

1.  Principles and Issues for Physical Frailty Measurement and Its Clinical Application.

Authors:  Karen Bandeen-Roche; Alden L Gross; Ravi Varadhan; Brian Buta; Michelle C Carlson; Megan Huisingh-Scheetz; Mara Mcadams-Demarco; Damani A Piggott; Todd T Brown; Rani K Hasan; Rita R Kalyani; Christopher L Seplaki; Jeremy D Walston; Qian-Li Xue
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-05-22       Impact factor: 6.053

2.  Development, Construct Validity, and Predictive Validity of a Continuous Frailty Scale: Results From 2 Large US Cohorts.

Authors:  Chenkai Wu; G John Geldhof; Qian-Li Xue; Dae H Kim; Anne B Newman; Michelle C Odden
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

3.  Sex Differences in Healthspan Predict Lifespan in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Authors:  Alice E Kane; Sooyoun Shin; Aimee A Wong; Emre Fertan; Natalia S Faustova; Susan E Howlett; Richard E Brown
Journal:  Front Aging Neurosci       Date:  2018-06-12       Impact factor: 5.750

4.  Frailty effects on non-demented cognitive trajectories are moderated by sex and Alzheimer's genetic risk.

Authors:  Sherilyn Thibeau; Kirstie McDermott; G Peggy McFall; Kenneth Rockwood; Roger A Dixon
Journal:  Alzheimers Res Ther       Date:  2019-06-21       Impact factor: 6.982

5.  Instruments for the detection of frailty syndrome in older adults: A systematic review.

Authors:  Jossiana Wilke Faller; David do Nascimento Pereira; Suzana de Souza; Fernando Kenji Nampo; Fabiana de Souza Orlandi; Silvia Matumoto
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

6.  Analysis of anticholinergic and sedative medicine effects on physical function, cognitive function, appetite and frailty: a cross-sectional study in Australia.

Authors:  Renly Lim; Lisa M Kalisch Ellett; Imaina S Widagdo; Nicole L Pratt; Elizabeth Ellen Roughead
Journal:  BMJ Open       Date:  2019-09-04       Impact factor: 2.692

7.  Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome.

Authors:  Renly Lim; Luke Bereznicki; Megan Corlis; Lisa M Kalisch Ellett; Ai Choo Kang; Tracy Merlin; Gaynor Parfitt; Nicole L Pratt; Debra Rowett; Stacey Torode; Joseph Whitehouse; Andre Q Andrade; Rebecca Bilton; Justin Cousins; Lan Kelly; Camille Schubert; Mackenzie Williams; Elizabeth Ellen Roughead
Journal:  BMJ Open       Date:  2020-04-22       Impact factor: 2.692

8.  Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial).

Authors:  Elizabeth E Roughead; Nicole L Pratt; Gaynor Parfitt; Debra Rowett; Lisa M Kalisch-Ellett; Luke Bereznicki; Tracy Merlin; Megan Corlis; Ai Choo Kang; Joseph Whitehouse; Rebecca Bilton; Camille Schubert; Stacey Torode; Thu-Lan Kelly; Andre Q Andrade; Dannielle Post; Gereltuya Dorj; Justin Cousins; Mackenzie Williams; Renly Lim
Journal:  Age Ageing       Date:  2022-04-01       Impact factor: 12.782

9.  Systematic review of the utility of the frailty index and frailty phenotype to predict all-cause mortality in older people.

Authors:  M Sofia Massa; Robert Clarke; Derrick A Bennett; Dani J Kim; Caroline M Potter
Journal:  Syst Rev       Date:  2022-09-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.